CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
Fan, Zheng, Devlin, Jennifer R., Hogg, Simon J., Doyle, Maria A., Harrison, Paul F., Todorovski, Izabela, Cluse, Leonie A., Knight, Deborah A. +13 more·2020·Science Advances
Cited by (171)
Items 101–171 of 171
- A Huluwa phosphorylation switch regulates embryonic axis inductionYao Li, Yun Yan, Bo Gong, Qianwen Zheng, Hai-Yan Zhou, Jiarui Sun, Mingpeng Li, Zhao Wang, Yaohui Li, Yunjing Wan et al. · 2024 · Nature Communications
- Genetic of preimplantation diagnosis of dysmorphic facial features and intellectual developmental disorder (CHDFIDD) without congenital heart defectsXiangrong Cui, Xueqing Wu, Hongwei Wang, Sanyuan Zhang, Wei Wang, Xuan Jing · 2022 · Molecular Genetics & Genomic Medicine
- Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 geneBin Wang, Yao Wang, Yi Wen, Yilin Zhang, Wei‐Jie Ni, Tao‐Tao Tang, Jing-Yuan Cao, Qing Yin, Wei Jiang, Di Yin et al. · 2022 · Molecular Therapy
- Case Report: Hemophagocytic Lymphohistiocytosis Prior to the Onset of Leukemia in a Boy With CDK13-Related DisorderDongyan Cui, Songmi Wang, Ai Zhang, Aiguo Liu, Qun Hu · 2022 · Frontiers in Genetics
- Cyclin‐dependent kinases as therapeutic targets in cancer: Recent advances, challenges, and opportunitiesNing Ju, Li Zhao, Shanshan Yin, Xiangrui Yang, Jin Zhou, Jinmin Gao, Feifei Qi · 2026 · International Journal of Cancer
- CDK13 ‐Related Disorder: Novel Insights From A Series of 27 Cases and Recommendations for Clinical ManagementGianluca Contrò, Maria Chiara Baroni, Stefano Giuseppe Caraffi, Manuela Napoli, Rosangela Artuso, Annarita Giliberti, Sara Bargiacchi, Giorgia Mancano, Giovanna Traficante, Mafalda Mucciolo et al. · 2025 · Clinical Genetics
- Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinomaYin Cao, Sen Huang, Yaohui He, Yuxiang Zhang, Simian Chen, Mengxian Huang, Fengming He, Shutong Chen, Lei Wang, Ziying Yang et al. · 2025 · Bioorganic Chemistry
- Organization and Dynamics of Transcription Elongation Foci in Mouse TissuesChihiro Matsuda, Akane Ichiki, Yuko Sato, Yukino Kudo, Mika Saotome, Chihiro Takayama, Le Minh Khoa, Satoshi Uchino, Ryota Higuchi, Kazuhiko Kawata et al. · 2025 · Journal of Molecular Biology
- The Promoter-Proximal Pause: A Decision Point Governing RNA Polymerase II FateUsman Hyder, David L. Bentley · 2026 · Annual Review of Biochemistry
- CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastomaSilje Lier, Sara Markusson, Anja Kocijancic, Martine Narum, Solveig Osnes Lund, Bianka Böllering, Anuja Lipsa, M. Dige Soegaard, Idun Dale Rein, Petra Sántha et al. · 2026 · EMBO Molecular Medicine
- Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defectsYilin Zhang, Tao‐Tao Tang, Wei‐Jie Ni, Zhong-Tang Li, Liang-Yun-Zi Jiang, Yao Wang, Xuan Zhou, Jing-Yuan Cao, Qing Yin, Wei Jiang et al. · 2024 · International Journal of Biological Sciences
- Molecular mechanisms of immune rejection against xenotransplantation in the pearl oyster Pinctada fucata revealed by serum proteomicsPei Wang, Ying Guo, Xiuxiu Sang, Tangrongjun Guo, Lipeng Yu, Tao Li, Yuewen Deng, Dahui Yu, Lirong Bai · 2024 · Aquaculture
- Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancerRazia Rahman, Luke A. Selth · 2025 · Translational Oncology
- Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturationAishwarya Gondane, Harri M. Itkonen · 2025 · Journal of Biomedical Science
- Gene Transcription as a Therapeutic Target in LeukemiaAlvina I. Khamidullina, Ekaterina A. Varlamova, Nour Alhuda Hammoud, Margarita A. Yastrebova, Alexandra V. Bruter · 2021 · International Journal of Molecular Sciences
- Borrowing Transcriptional Kinases to Activate ApoptosisRoman C. Sarott, Sai P. Gourisankar, Basel A. Karim, Sabin A. Nettles, Haopeng Yang, Brendan G. Dwyer, Juste Simanauskaite, Jason Tse, Hind Z. Abuzaid, A. Krokhotin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · eLife
- Internal and external normalization of nascent RNA sequencing run-on experimentsZachary L. Maas, Robin D. Dowell · 2024 · BMC Bioinformatics
- CDK12 Is Necessary to Promote Epidermal Differentiation Through Transcription ElongationJingting Li, Manisha Tiwari, Yifang Chen, Sudjit Luanpitpong, George L. Sen · 2022 · Stem Cells
- CAPTURE of the Human U2 snRNA Genes Expands the Repertoire of Associated FactorsJoana Guiro, Mathias Fagbemi, Michael Tellier, Justyna Zaborowska, Stephanie Barker, Marjorie L. Fournier, Shona Murphy · 2022 · Biomolecules
- Advancements in chemical biology targeting the kinases and phosphatases of RNA polymerase II-mediated transcriptionWantae Kim, Blase M. LeBlanc, Wendy L. Matthews, Zhong‐Yin Zhang, Yan Zhang · 2021 · Current Opinion in Chemical Biology
- Absence of CDK12 in oocyte leads to female infertilityDenisa Jansová, Veronika Sedmikova, Fatima J. Berro, Daria Aleshkina, Michal Dvoran, Michal Kubelka, Jitka Rezacova, Jana Rutarova, Jiří Kohoutek, Andrej Šušor · 2025 · Cell Death and Disease
- Discovery of DN1679 as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast CancerDanni Chen, Jiawen Hu, Y. Shane Yu, Kailin Li, Tingting Wang, Zidong Wang, Yi Yuan, Xuejing Shao, Meidan Ying, Bo Yang et al. · 2025 · Journal of Medicinal Chemistry
- CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targetingJulia Dudkiewicz-Garbicz, Pawel Krzysztof Wlodarski · 2026 · Cellular Oncology
- CPSF73 activation and 3′ RNA polymerase II pausing are lost during readthrough transcription after heat shockKaitlyn E. Walsh, James A. Goodrich, Jennifer F. Kugel · 2026 · Cell Reports
- The Bidirectional Link Between RNA Cleavage and Polyadenylation and Genome Stability: Recent Insights From a Systematic ScreenStefano Spada, Brian Luke, Sven Danckwardt · 2022 · Frontiers in Genetics
- CDK12/13 inhibitor, CTX-439, suppresses tumor growth and potentiates BCL-2 family blockadeHiroko Yamakawa, Raghda Khatab, Akio Mizutani, Shunsuke Ebara, Takaharu Hirayama, Sunao Tanaka, Yusuke Tarumoto, Midori Sugiyama, Seiichi Sugino, Mariko Takano et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Targeting CDK7/12/13 functional synergism reverses myofibroblast activation and ameliorates lung fibrosisHsiao‐Yen Ma, Zhiyu Huang, Surinder Jeet, Claire Emerson, Hannah S. Bender, Qihao Ren, Ning Ding · 2025 · iScience
- UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12Sijie Xie, Shuting Song, Xinlei Liu, Dongdong Lu · 2025 · Cell Biology International
- Discovery of a Selective and Potent Inhibitor of Cyclin-Dependent Kinase 12/13 Employing a Noncovalent MechanismRobert A. Swyka, Evan D. Styduhar, Anlai Wang, Xin Li, Ke Zhang, Michael R. Witten, Peng Zhao, Michael Z. Liang, Onur Atasoylu, Peng He et al. · 2026 · ACS Medicinal Chemistry Letters
- Cytoplasmic mRNA decay by the antiviral nuclease RNase L promotes transcriptional repressionXiaowen Mao, Sherzod A. Tokamov, Felix Pahmeier, Azra Lari, Jinyi Xu, Eva Harris, Britt A. Glaunsinger · 2026 · Cell Reports
- Alternative polyadenylation in cancer: mechanisms, functions, and therapeutic potentialYu Huang, Zhihong Li, Fenglei Yu, Lujuan Wang · 2026 · Molecular Cancer
- Human Genetics of Atrial Septal DefectLars Allan Larsen, Marc‐Phillip Hitz · 2024 · Advances in experimental medicine and biology
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
- Mitotic phosphorylation of ADAR1 regulates its centromeric localization and is required for faithful mitotic progressionYuxi Yang, Mai Kubota, Kokone Hasegawa, Chao Zeng, Kazuko Nishikura, Michiaki Hamada, Masayuki Sakurai · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2025 · eLife
- The PAF1 Complex Recruits Integrator to Chromatin Globally to Terminate Non-Productive TranscriptionXinhong Liu, Ziwei Guo, Jing Han, Bin Zhang, Xiaoyu Hu, Charles J. David, Mo Chen · 2021 · SSRN Electronic Journal
- Age- or Lifestyle-Induced Accumulation of Genotoxicity Is Associated With a Generalized Shutdown of Long Gene TranscriptionOlga Ibáñez-Solé, Ander Izeta · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
- Data from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription ElongationTiziana Monteverde, Sudhakar Sahoo, Manuela La Montagna, Peter Magee, Lei Shi, Dave Chi Hoo Lee, Robert Sellers, Alexander R. Baker, Hui Sun Leong, Matteo Fassan et al. · 2023
- Data from Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian CancerLin Cheng, Shichao Zhou, Shaoqing Zhou, Kaixuan Shi, Yan Cheng, Mei‐Chun Cai, Kaiyan Ye, Lifeng Lin, Zhenfeng Zhang, Chenqiang Jia et al. · 2023
- Tumor suppression by RNA surveillanceRobert P. Fisher · 2023 · Science
- The spreading of facultative H3K9me3-heterochromatin drives congenital diseaseChen Wang, Wei Zhang, Xuelin Chen, Wenfei Wang, Yong-Hao Li, Jian-Feng Chang, Xiao-Bo Guo, Yuanya Jing, Yabin Li, Xinyi Lu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
- Ubiquitylation of RNA Polymerase II Controls Early Stages of the Transcription CycleRoberta Cacioppo, Alexander Gillis, Iván Shlamovitz, Andrew Zeller, Daniela Castiblanco, Alastair Crisp, Benjamin Haworth, Angela Arabiotorre, Pegah Abyaneh, Yu Bao et al. · 2024 · SSRN Electronic Journal
- A pathogenic missense variant, c.2149G>A (p.Gly717Arg), in CDK13 in a female patient with CDK13-related disorder: A case report and literature review of 112 casesNaoki Morooka, Jun Kido, Hiroe Ueno, Yohei Misumi, Keishin Sugawara, Shinichi Kameyama, Hiromi Fukuda, Takeshi Mizuguchi, Naomichi Matsumoto, Mitsuharu Ueda et al. · 2024 · Brain and Development Case Reports
- Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate CancerFu Gui, Baishan Jiang, Jie Jiang, Zhixiang He, Takuya Tsujino, Tomoaki Takai, Seiji Arai, Celine Pana, Jens W. Köllermann, Gary Andrew Bradshaw et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · eLife
- Congenital Heart Defects, Dysmorphic Facial Features, and Intellectual Developmental Disorder (CHDFIDD)Asmae Akbari · 2025 · Springer eBooks
- (R)-6-[N-(3-(4-chlorophenyl) propyl] derivative of (R)-roscovitine inhibits lung carcinoma progression via cyclin-dependent kinase suppressionJie Guo, Jianshe Chen, Weijie Li, Jinwen Yang, Abdul Basit, Siwei Zhang, Shuojie Wang · 2025 · Bioorganic & Medicinal Chemistry
- Overexpression of CCNK Leads to Early Resumption of Meiosis in Mouse OocytesYuan‐Hong Xu, Simin Sun, Bin Zhao, Jia‐Ni Guo, Xue‐Mei Yang, Yi‐Ke Lu, Yina Zhang, Ding Ji, Zhen‐Bo Wang · 2025 · Molecular Reproduction and Development
- Additional file 3 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
- Additional file 2 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
- Additional file 1 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
- Additional file 1 of Internal and external normalization of nascent RNA sequencing run-on experimentsZachary L. Maas, Robin D. Dowell · 2024 · Figshare
- Additional file 4 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
- Additional file 2 of Internal and external normalization of nascent RNA sequencing run-on experimentsZachary L. Maas, Robin D. Dowell · 2024 · Figshare
- SF3B1 Phosphorylation Prompts U2AF2 Dissociation for Widespread Control of pre-mRNA SplicingChristopher L. Kirchhoff, Hannah R. Powell, Justin W. Galardi, Sarah Loerch, Mary J. Pulvino, Jermaine L. Jenkins, Paul L. Boutz, Clara L. Kielkopf · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- The RNA Editome of Esophageal Squamous Cell Carcinoma Identifies an ADAR1-CDK13 Editing Feedback Loop Mediating cGAS–STING Activation in Early TumorigenesisLihong Huang, Mingle Yang, D. Z. Li, Guozhong Jiang, Wenliang Zhang · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Pre-mRNA 3'-end polyadenylation : impact on UV-induced DNA damage and on the translatability of immune-related genesBiswendu Biswas · 2022 · theses.fr (ABES)
- CDK12 and CDK13 suppress distinct intronic polyadenylation sitesMolly J. Hulver, Andrew Polevoda, Kai-Lieh Huang, Eric J. Wagner, Paul L. Boutz · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Cyclin K condensates bridge CDK12 to phosphorylate and drive oncogenic YAP activation in hepatocellular carcinomaYang Sun, Yu Zhang, W W Yan, Jinlin Duan, Ke Qiao, Guoquan Yan, Junyan Xue, Jie Wang, Ming Zhan, Qi Li et al. · 2026 · Science Advances
- Termination dynamics set RNAPII elongation rate and gate the response to CDK12 inactivationOliver Ozaydin, Lin Liu, Dáire Gannon, Mina Haddawi, Chloe A. N. Gerak, Sarahi Rivera, Laura Corso, Maede Salehi, Mengbo Li, Yining Tian et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Mechanisms of transcription termination across the coding and noncoding loci of the genomeAixia Song, Minhui Hu, Fei Chen · 2026 · Nature Reviews Molecular Cell Biology
- Synthesis and antitumoral evaluation of 3′,4′-unsaturated nucleoside analogues bearing a chlorinated remdesivir-like baseSong Wang, Jing Yang, Xinyue Yang, Hao Huang, Haiyang Zou, Yu Zhang, Xushan Zhang, Congcong Luo, Bing Zhao, Feng‐Wu Liu et al. · 2026 · Bioorganic Chemistry
- Cyclins and Cyclin‐Dependent Kinases: Structure, Biological Functions, and Innovative Targeting Strategies in CancerSuya Zheng, Zhipeng Shen, Yuanfang Wu, Xingze Huang, Zhongyuan Zhang, Jiangyu Liu, Qichun Wei, Wenhao Chen, Ye Chen, Liang Xu · 2026 · MedComm
- Transcriptional kinases drive gene expression network plasticityDavid Daesung Lowe, Ali Shilatifard · 2026 · Molecular Cell
- Targeting CDKs in the RNAPII transcription cycleRobert P. Fisher, Matthias Geyer · 2026 · Nature Reviews Drug Discovery
- A guide to transcriptional cyclin‐dependent kinases in cancerJennifer R. Devlin, Salla Kyheröinen, Ricky W. Johnstone · 2026 · FEBS Journal
- Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastomaJoshua Robert Goulding, Stijn Tim Couwenbergh, Sarah-Lee Bekaert, Ellen Sanders, Fanny De Vloed, Vicky Amo-Addae, Aline Eggermont, Jolien De Wyn, Kaat De Wever, Lasse Vleminckx et al. · 2026 · Cell Reports
- BindingDB Entry 50015218: Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor.BindingDB · 2023 · UC San Diego
- BindingDB Entry 50016375: Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13.BindingDB · 2023 · UC San Diego
- BindingDB Entry 50015910: Current progress and novel strategies that target CDK12 for drug discovery.BindingDB · 2023 · UC San Diego